IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 71 filers reported holding IMMUNIC INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,126 | +21.6% | 352,467 | +107.7% | 0.00% | 0.0% |
| Q2 2023 | $425,924 | -1.7% | 169,691 | -41.6% | 0.00% | 0.0% |
| Q1 2023 | $433,095 | +10.1% | 290,668 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $393,491 | +13.4% | 281,065 | +156.1% | 0.00% | 0.0% |
| Q3 2022 | $347,000 | -49.3% | 109,760 | -44.4% | 0.00% | -50.0% |
| Q2 2022 | $684,000 | -19.5% | 197,251 | +162.3% | 0.00% | -33.3% |
| Q1 2022 | $850,000 | -31.4% | 75,199 | -41.9% | 0.00% | 0.0% |
| Q4 2021 | $1,239,000 | -0.1% | 129,457 | -7.6% | 0.00% | 0.0% |
| Q3 2021 | $1,240,000 | -34.4% | 140,067 | -9.1% | 0.00% | -25.0% |
| Q2 2021 | $1,890,000 | -23.0% | 154,160 | +0.1% | 0.00% | -33.3% |
| Q1 2021 | $2,454,000 | -19.6% | 153,983 | -22.8% | 0.01% | -33.3% |
| Q4 2020 | $3,051,000 | -11.4% | 199,541 | +7.6% | 0.01% | -25.0% |
| Q3 2020 | $3,443,000 | +1878.7% | 185,393 | +1194.7% | 0.01% | +1100.0% |
| Q2 2020 | $174,000 | – | 14,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |